347 related articles for article (PubMed ID: 35373463)
1. Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma.
Ping S; Wang S; Zhao Y; He J; Li G; Li D; Wei Z; Chen J
Cancer Med; 2022 Sep; 11(18):3529-3541. PubMed ID: 35373463
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
Diao X; Guo C; Liu L; Wang G; Li S
Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
[TBL] [Abstract][Full Text] [Related]
3. Multi
Wu M; Li K; Liao Y; Li L; Xiao X; Chen Y; Guo J; Hu F; Qu J; Wang Z; Feng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):159-174. PubMed ID: 38755712
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma.
Liu C; Liu Y; Yu Y; Zhao Y; Yu A
BMC Med Genomics; 2022 Mar; 15(1):39. PubMed ID: 35232428
[TBL] [Abstract][Full Text] [Related]
5. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma.
Guo S; Chen J; Yi X; Lu Z; Guo W
Front Immunol; 2022; 13():985051. PubMed ID: 36248853
[TBL] [Abstract][Full Text] [Related]
7. Identification of a prognostic signature based on five ferroptosis-related genes for diffuse large B-cell lymphoma.
Li W; Yao R; Yu N; Zhang W
Cancer Biomark; 2024; 40(1):125-139. PubMed ID: 38517778
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
Front Surg; 2022; 9():860806. PubMed ID: 35937602
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a prognostic model for melanoma patients with 9 ferroptosis-related gene signature.
Chen Y; Guo L; Zhou Z; An R; Wang J
BMC Genomics; 2022 Mar; 23(1):245. PubMed ID: 35354376
[TBL] [Abstract][Full Text] [Related]
11. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
Tian M; Yang J; Han J; He J; Liao W
Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of Ferroptosis-Related DNA Methylation Signature for Predicting the Prognosis and Guiding the Treatment in Cutaneous Melanoma.
Guo W; Wang X; Wang Y; Zhu S; Zhu R; Zhu L
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555319
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis-related genes are candidate diagnostic and prognostic biomarkers for skin cutaneous melanoma.
Jing HY; Gu W; Tan XY; Ma YR
Biomark Med; 2022 Feb; 16(3):179-196. PubMed ID: 35057634
[TBL] [Abstract][Full Text] [Related]
14. Construction and Validation of a 6-Ferroptosis Related Gene Signature for Prognosis and Immune Landscape Prediction in Melanoma.
Yue Z; Sun J; Shi L
Front Genet; 2022; 13():887542. PubMed ID: 35692844
[TBL] [Abstract][Full Text] [Related]
15. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
[TBL] [Abstract][Full Text] [Related]
16. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y
Front Oncol; 2021; 11():686044. PubMed ID: 34422642
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.
Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J
Front Immunol; 2022; 13():922315. PubMed ID: 35774794
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
[TBL] [Abstract][Full Text] [Related]
19. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
[TBL] [Abstract][Full Text] [Related]
20. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
Zhou J; Wang X; Li Z; Jiang R
FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
